I-SPY 2 TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer

This study is currently recruiting participants.

Verified March 2013 by Foundation for the National Institutes of Health

Study NCT01042379 Information provided by Foundation for the National Institutes of Health

First Received on December 31, 2009. Last Updated on March 14, 2013 History of Changes

Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:

Conditions listed in this trial

Breast Neoplasms
Breast Cancer
Breast Tumors

Additional conditions recognized in this trial

Neoplasms

More general conditions related to this trial

Interventions listed in this trial

Additional drug interventions recognized in this trial

Metformin
Trastuzumab

More general drug interventions related to this trial

Sponsors listed in this trial